Neurobiological Technologies, Inc. To Present At The Fourth Annual Tucker Anthony Sutro Healthcare Conference with Simultaneous Web Cast

Apr 04, 2001, 01:00 ET from Neurobiological Technologies, Inc.

    RICHMOND, Calif., April 4 /PRNewswire/ -- Neurobiological Technologies,
 Inc. or (NTI(R)) (Nasdaq:   NTII) today announced that its presentation at the
 Tucker Anthony Sutro Capital Markets Life Science and Healthcare Conference in
 Laguna Niguel, California will be web cast over the Internet.  NTI's
 presentation is scheduled for Friday, April 6, 2001 at 9:10 am, PDT (12:10 pm
 EDT).  To access the live web cast please visit http://www.ntii.com and go to
 the "Investors" section of the web site.  A replay of the web cast will be
 available at http://www.ntii.com until Friday, April 20, 2001.
 
     NTI is an emerging drug development company focused on the clinical
 development and regulatory approval of neuroscience drugs.  The company's
 strategy is to in-license and develop early-stage drug candidates that target
 major medical needs and which can be rapidly commercialized.  The company's
 experienced management team oversees the human clinical trials necessary to
 establish preliminary evidence of efficacy and seeks partnerships with
 pharmaceutical and biotechnology companies to complete development of and
 market its product candidates.
 
     NOTE:  Except for the historical information contained herein, the matters
 discussed in this press release are forward-looking statements that involve
 risks and uncertainties, including our reliance on our collaborative partners
 and our ability to properly design, implement and complete clinical trial;
 meet regulatory requirement; demonstrate safety and efficacy for product;
 manage third-party contractor; and avoid infringement of third-party
 proprietary rights, as well as other risks detailed from time to time in our
 Securities and Exchange Commission filings.  Actual results may differ
 materially from those projected.  These forward-looking statements represent
 our judgment as of the date of the release.  We disclaim any intent or
 obligation to update these forward-looking statements.
 
 

SOURCE Neurobiological Technologies, Inc.
    RICHMOND, Calif., April 4 /PRNewswire/ -- Neurobiological Technologies,
 Inc. or (NTI(R)) (Nasdaq:   NTII) today announced that its presentation at the
 Tucker Anthony Sutro Capital Markets Life Science and Healthcare Conference in
 Laguna Niguel, California will be web cast over the Internet.  NTI's
 presentation is scheduled for Friday, April 6, 2001 at 9:10 am, PDT (12:10 pm
 EDT).  To access the live web cast please visit http://www.ntii.com and go to
 the "Investors" section of the web site.  A replay of the web cast will be
 available at http://www.ntii.com until Friday, April 20, 2001.
 
     NTI is an emerging drug development company focused on the clinical
 development and regulatory approval of neuroscience drugs.  The company's
 strategy is to in-license and develop early-stage drug candidates that target
 major medical needs and which can be rapidly commercialized.  The company's
 experienced management team oversees the human clinical trials necessary to
 establish preliminary evidence of efficacy and seeks partnerships with
 pharmaceutical and biotechnology companies to complete development of and
 market its product candidates.
 
     NOTE:  Except for the historical information contained herein, the matters
 discussed in this press release are forward-looking statements that involve
 risks and uncertainties, including our reliance on our collaborative partners
 and our ability to properly design, implement and complete clinical trial;
 meet regulatory requirement; demonstrate safety and efficacy for product;
 manage third-party contractor; and avoid infringement of third-party
 proprietary rights, as well as other risks detailed from time to time in our
 Securities and Exchange Commission filings.  Actual results may differ
 materially from those projected.  These forward-looking statements represent
 our judgment as of the date of the release.  We disclaim any intent or
 obligation to update these forward-looking statements.
 
 SOURCE  Neurobiological Technologies, Inc.